Published in Ann Oncol on May 11, 2007
Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA (2008) 2.73
Bladder cancer SNP panel predicts susceptibility and survival. Hum Genet (2009) 1.43
Air pollution: a potentially modifiable risk factor for lung cancer. Nat Rev Cancer (2013) 1.15
Examining the joint effect of multiple risk factors using exposure risk profiles: lung cancer in nonsmokers. Environ Health Perspect (2010) 1.13
Bladder cancer epidemiology and genetic susceptibility. J Biomed Res (2013) 0.95
A bird's eye view of the air pollution-cancer link in China. Chin J Cancer (2014) 0.92
Genetic modifiers of carcinogen DNA adducts in target lung and peripheral blood mononuclear cells. Carcinogenesis (2010) 0.91
Polymorphisms of methylenetetrahydrofolate reductase and methionine synthase genes and bladder cancer risk: a case-control study with meta-analysis. Clin Exp Med (2008) 0.85
Polymorphisms of NRF2 and NRF2 target genes in urinary bladder cancer patients. J Cancer Res Clin Oncol (2014) 0.79
Polymorphisms in CYP1B1, CYP3A5, GSTT1, and SULT1A1 Are Associated with Early Age Acute Leukemia. PLoS One (2015) 0.79
Methylenetetrahydrofolate reductase C677T polymorphism in patients with lung cancer in a Korean population. BMC Med Genet (2011) 0.79
Methylenetetrahydrofolate reductase polymorphisms and interaction with smoking and alcohol consumption in lung cancer risk: a case-control study in a Japanese population. BMC Cancer (2011) 0.78
Genetic polymorphisms in NQO1 and SOD2: interactions with smoking, schistosoma infection, and bladder cancer risk in Egypt. Urol Oncol (2013) 0.77
Influence of methylenetetrahydrofolate reductase C677T polymorphism on the risk of lung cancer and the clinical response to platinum-based chemotherapy for advanced non-small cell lung cancer: an updated meta-analysis. Yonsei Med J (2013) 0.77
Interactive effect of smoking and NQO1 haplotypes on lung cancer risk. J Korean Med Sci (2015) 0.76
Prevalence of at-risk genotypes for genotoxic effects decreases with age in a randomly selected population in Flanders: a cross sectional study. Environ Health (2011) 0.75
CYP1A1 and GSTP1 gene variations in breast cancer: a systematic review and case-control study. Fam Cancer (2016) 0.75
Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. IARC Sci Publ (1987) 27.11
Statistical methods in cancer research. Volume I - The analysis of case-control studies. IARC Sci Publ (1980) 15.47
General and abdominal adiposity and risk of death in Europe. N Engl J Med (2008) 14.49
The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet (2002) 10.52
Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975-1981. Lancet (1984) 10.22
European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr (2002) 8.77
Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet (1987) 6.91
Active and passive smoking and pathological indicators of lung cancer risk in an autopsy study. JAMA (1992) 6.56
The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA (1997) 6.32
Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst (2003) 6.20
What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial. Br J Cancer (1987) 6.20
Randomized study comparing the "sniffing position" with simple head extension for laryngoscopic view in elective surgery patients. Anesthesiology (2001) 6.19
Consequences of assessment and intervention among elderly people: a three year randomised controlled trial. Br Med J (Clin Res Ed) (1984) 6.00
Evaluation of screening for breast cancer in a non-randomised study (the DOM project) by means of a case-control study. Lancet (1984) 5.87
Physical activity and the risk of breast cancer. N Engl J Med (1997) 5.85
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit. J Epidemiol Community Health (1989) 5.20
Disease susceptibility genes--their identification by multiple case family studies. Tissue Antigens (1976) 5.17
Estimation of multiple relative risk functions in matched case-control studies. Am J Epidemiol (1978) 4.76
The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol (1997) 4.73
Simplified models of screening for chronic disease: estimation procedures from mass screening programmes. Biometrics (1984) 4.73
Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab (1998) 4.63
Mediterranean diet pyramid: a cultural model for healthy eating. Am J Clin Nutr (1995) 4.50
Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer (1997) 4.47
Monitoring the prevalence of HIV. BMJ (1989) 4.46
Hybridization of labeled RNA to DNA in agarose gels. Nucleic Acids Res (1975) 4.38
Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am (1992) 4.34
Comparison of dietary assessment methods in nutritional epidemiology: weighed records v. 24 h recalls, food-frequency questionnaires and estimated-diet records. Br J Nutr (1994) 4.32
A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer (2002) 4.18
Estimation of the duration of a pre-clinical disease state using screening data. Am J Epidemiol (1983) 4.11
A case-control study of the efficacy of a non-randomized breast cancer screening program in Florence (Italy). Int J Cancer (1986) 4.11
End-of-life decisions in neonatal intensive care: physicians' self-reported practices in seven European countries. EURONIC Study Group. Lancet (2000) 4.01
tRNA genes are found between 16S and 23S rRNA genes in Bacillus subtilis. Nucleic Acids Res (1982) 3.93
The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer (1992) 3.88
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Validation of dietary assessment methods in the UK arm of EPIC using weighed records, and 24-hour urinary nitrogen and potassium and serum vitamin C and carotenoids as biomarkers. Int J Epidemiol (1997) 3.79
Coronary heart-disease after treatment of hypertension. Lancet (1978) 3.78
Breast cancer treatment and natural history: new insights from results of screening. Lancet (1992) 3.77
Multicenter case-control study of exposure to environmental tobacco smoke and lung cancer in Europe. J Natl Cancer Inst (1998) 3.74
Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature (1978) 3.73
3' end formation of U1 snRNA precursors is coupled to transcription from snRNA promoters. Cell (1986) 3.61
Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst (2000) 3.57
Multistage models and primary prevention of cancer. J Natl Cancer Inst (1980) 3.55
Polymorphisms associated with circulating sex hormone levels in postmenopausal women. J Natl Cancer Inst (2004) 3.53
Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev (2001) 3.43
Relative validity and reproducibility of a food frequency dietary questionnaire for use in the Italian EPIC centres. Int J Epidemiol (1997) 3.39
Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genet Epidemiol (2001) 3.35
Dietary effects on breast-cancer risk in Singapore. Lancet (1991) 3.32
Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry. Anal Biochem (1995) 3.19
Parental visiting, communication, and participation in ethical decisions: a comparison of neonatal unit policies in Europe. Arch Dis Child Fetal Neonatal Ed (1999) 3.14
The constitutive transport element (CTE) of Mason-Pfizer monkey virus (MPMV) accesses a cellular mRNA export pathway. EMBO J (1997) 3.10
Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols, and dioxins. An expanded and updated international cohort study. Am J Epidemiol (1997) 3.10
Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer (2005) 3.04
A case-control study of cervical cancer screening in north east Scotland. Br Med J (Clin Res Ed) (1985) 2.98
Oesophageal cancer studies in the Caspian Littoral of Iran: the Caspian cancer registry. Br J Cancer (1973) 2.93
Transcription of a gene for human U1 small nuclear RNA. Cell (1982) 2.93
Shift work and chronic disease: the epidemiological evidence. Occup Med (Lond) (2011) 2.93
Separating the retinal electrophysiologic effects of vigabatrin: treatment versus field loss. Neurology (2000) 2.90
The detection of gene-environment interaction for continuous traits: should we deal with measurement error by bigger studies or better measurement? Int J Epidemiol (2003) 2.89
The impact of screening on the incidence of cervical cancer in England and Wales. Br J Obstet Gynaecol (1985) 2.83